Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Sulfur – selenium or tellurium compound
Reexamination Certificate
2007-06-26
2007-06-26
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Sulfur, selenium or tellurium compound
Reexamination Certificate
active
10945810
ABSTRACT:
This invention relates to a method of treating patients who are receiving dialysis treatments. The method includes administering to a patient in need of treatment an effective amount of a thiol or reducible disulfide compound according to the formula set forth in the specification.
REFERENCES:
patent: 5302609 (1994-04-01), Shayman et al.
patent: 5661188 (1997-08-01), Weissman et al.
patent: 6031006 (2000-02-01), Hausheer et al.
patent: 6172119 (2001-01-01), Hausheer
patent: 6537976 (2003-03-01), Gupta
patent: 2003/0040507 (2003-02-01), Nickel et al.
patent: 2004/0096845 (2004-05-01), Sakai et al.
The Merck Manual of Diagnosis and Therapy, 14th Edition, published 1982 by Merck Sharp & Dohme Research Laboratories, pp. 1510-1515.
The Merck Manual of Diagnosis and Therapy, 14thEdition, published 1982 by Merck Sharp & Dohme Research Laboratories, (NJ), pp. 1518-1527.
Bio Numerik Pharmaceuticals, Inc.
Dodd Thomas J.
Henley III Raymond J.
Whitaker Scott A.
LandOfFree
Method of treating patients undergoing kidney dialysis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating patients undergoing kidney dialysis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating patients undergoing kidney dialysis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3822498